Related Experiment Video

Updated: Jul 15, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Genetics of dilated cardiomyopathy

Satu Kärkkäinen1, Keijo Peuhkurinen

  • 1Kuopio University and Kuopio University Hospital, Kuopio, Finland. satu.karkkaninen@kuh.fi

Annals of Medicine
|April 25, 2007
PubMed

Insights

Genetic factors are increasingly recognized in dilated cardiomyopathy (DCM), a heart muscle disease. Understanding the genetic basis of DCM is crucial for developing targeted treatments and improving patient outcomes.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Dilated cardiomyopathy (DCM) is a myocardial disease affecting left or both ventricles, leading to impaired systolic function.
  • While multifactorial, genetic factors are increasingly implicated in the etiology and pathogenesis of idiopathic DCM.
  • Recent research highlights the heterogeneous genetic background of DCM, with mutations found in various protein-encoding genes.

Purpose of the Study:

  • To review the current understanding of the genetic basis of dilated cardiomyopathy.
  • To explore the identified genetic mutations and their roles in DCM pathogenesis.
  • To discuss the implications of genetic findings for future treatment strategies and patient outcomes.

Main Methods:

  • This review synthesizes recent findings from genetic studies on dilated cardiomyopathy.
  • It examines mutations in genes encoding sarcomeric, cytoskeletal, and nuclear proteins, as well as those involved in calcium metabolism.
  • The review discusses the complex mechanisms linking genetic defects to heart failure.

Main Results:

  • Genetic factors play a significant role in the etiology of idiopathic DCM.
  • Mutations are identified in genes crucial for cardiac structure and function, including sarcomeric, cytoskeletal, and nuclear proteins.
  • The genetic landscape of DCM is heterogeneous, with many mutations affecting limited patient populations.

Conclusions:

  • Enhanced knowledge of DCM genetics is vital for personalized early treatment and novel therapeutic development.
  • Understanding disease-causing mechanisms can improve cardiac outcomes for patients with genetically linked DCM.
  • Further research into the genetic underpinnings of DCM is essential for advancing clinical management.

More Related Videos

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...